Suppr超能文献

结核性与非结核性脑膜炎脑脊液腺苷脱氨酶的对比分析

Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis.

作者信息

Moghtaderi Ali, Niazi Abbasali, Alavi-Naini Roya, Yaghoobi Saideh, Narouie Behzad

机构信息

Department of Neurology, Zahedan University of Medical Sciences, Zahedan, Iran.

出版信息

Clin Neurol Neurosurg. 2010 Jul;112(6):459-62. doi: 10.1016/j.clineuro.2009.12.006.

Abstract

OBJECTIVE

To calculate cut-off point for the adenosine deaminase (ADA) activity in the CSF of patients with tuberculous meningitis (TBM).

PATIENTS AND METHODS

The ADA assay was based on the automatic indirect method in which ADA catalyzes adenosine to inosine. ADA activity in the CSF was calculated based on ammonia liberated from adenosine and quantified spectrophotometrically. Arithmetic mean values and standard deviation of each variable were measured. Mann-Whitney U and Fisher exact tests were applied to compare continuous and dichotomous variables between tuberculous and non-tuberculous groups. A receiver operating characteristic curve was plotted to identify various cut-off points to determine the best level for ADA activity.

RESULTS

Totally 42 patients were enrolled into the study. The median of ADA activity in the TBM group was 22 and in the non-TBM group was 8.0. The mean CSF-ADA activity was found to be significantly higher in TBM group (23.05+/-13.1IU/L) than in the CSF from non-TBM patients (9.39+/-5.18IU/L). The highest accuracy is at the cut-off value of 10.5IU/L. The sensitivity and specificity of the test at this cut-off to differentiate TBM from non-tuberculous meningitis is 81% and 86% respectively.

CONCLUSION

Considering that a high positive value of ADA activity cannot confirm TBM, however, in suspected patients it may lead the physician to treat patient earlier before the confirmatory diagnostic reports will be received. The suggested cut-off value in this pilot study is 10.5IU/L with high sensitivity and specificity.

摘要

目的

计算结核性脑膜炎(TBM)患者脑脊液中腺苷脱氨酶(ADA)活性的截断点。

患者与方法

ADA检测基于自动间接法,即ADA催化腺苷转化为肌苷。脑脊液中的ADA活性通过腺苷释放的氨进行计算,并采用分光光度法定量。测量每个变量的算术平均值和标准差。应用曼-惠特尼U检验和费舍尔精确检验比较结核组和非结核组之间的连续变量和二分变量。绘制受试者工作特征曲线以确定不同的截断点,从而确定ADA活性的最佳水平。

结果

共有42例患者纳入本研究。TBM组ADA活性中位数为22,非TBM组为8.0。发现TBM组脑脊液ADA平均活性(23.05±13.1IU/L)显著高于非TBM患者的脑脊液(9.39±5.18IU/L)。截断值为10.5IU/L时准确性最高。该截断值区分TBM与非结核性脑膜炎的试验敏感性和特异性分别为81%和86%。

结论

考虑到ADA活性高阳性值不能确诊TBM,然而,在疑似患者中,它可能会使医生在收到确诊诊断报告之前更早地对患者进行治疗。本初步研究建议的截断值为10.5IU/L,具有较高的敏感性和特异性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验